Measuring the Success of AOM Coverage

Obesity Care in Health Systems

In the final episode of this podcast series, Dr. Christopher E. Weber discusses the critical role of health systems in delivering comprehensive obesity care. He outlines an step-by-step approach to developing an effective obesity care pathway, including identifying champions, targeting high-need patients, leveraging electronic health records for timeline intervention, and establishing systems for ongoing monitoring and improvement. He highlights how health systems can partner with local employers to expand access to obesity treatments and drive better health outcomes. Ultimately, he advocates for standardizing obesity care, just as with other chronic conditions, to ensure patients receive consistent, evidence-based support and treatment.    This program is intended for employers, payers, and health systems in the US only. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Measuring the Success of AOM Coverage

Join Dr. Terry McInnis as she outlines how to effectively measure the success of AOM coverage. She explains why it is essential for employers to track outcomes, offering a practical framework that includes stakeholder engagement, goal setting, budget impact assessment, and ongoing monitoring. Dr. McInnis also shares key metrics, benchmarks, and insights to help employers evaluate impact and ensure long-term success through continuous planning and evaluation. This program is intended for employers, payers, and health systems in the US only. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Adding and Managing AOM Coverage

Join Dr. Terry McInnis as she explores the current landscape of anti-obesity medication (AOM) coverage. She outlines the key stakeholders—PBMs, insurers, employers, benefits consultants, government agencies, and advocacy groups—and how they shape access. Dr. McInnis discusses the growing demand for comprehensive obesity benefits as employees become more aware of obesity-related health risks. She reviews the range of AOM coverage options, describes what a comprehensive obesity benefits program includes, and explains how employers can implement AOM coverage for their workforce and why employers should evaluate and monitor the utilization and outcomes of the program effectiveness and employee satisfaction.   This program is intended for employers, payers, and health systems in the US only. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

AOM Coverage in the Workplace

Please join host Patricia Stark and Patrick Beers, an expert in the field of Market Access and Reimbursement, as they discuss the coverage of AOMs, define AOMs, explore the importance of them, address the key players in AOM coverage, and highlight the demand for AOM coverage. They also explain the growing desire for employees to have access to AOMs through their employers and the greater recognition of obesity as a chronic disease that requires long-term management, leading to more robust coverage of AOMs.    This program is intended for employers, payers, and health systems in the US only. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Obesity Management in the Workplace

Please join host Patricia Stark and Dr. Gabriele Smolarz, endocrinologist and Executive Director of U.S. Medical Affairs at Novo Nordisk, as they explore the impact of obesity management in the workplace. Dr. Gabriele Smolarz breaks down how appetite is regulated, what defines obesity, and its association with certain chronic diseases and increased healthcare costs, and outlines weight management options and medical guidelines for a comprehensive approach to managing obesity.    This program is intended for employers, payers, and health systems in the US only. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.